Catalog #: PB14443
CAS No.: 475207-59-1
Formula: C21H16ClF3N4O3
Mol Weight: 464.825 g/mol
Purity: NLT 98%
MDL Number: MFCD06411450
Synonyms: 1-(4-(2-(Methylcarbamoyl)pyridin-4-yloxy)phenyl)-3-(4-chloro-3-(trifluoromethyl)phenyl)urea;2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-;4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide;4-(4-[3-(4-Chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy)-pyridine-2-carboxylic acid methylamide;4-[4-([[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl]amino)phenoxy]-N-methyl-2-pyridinecarboxamide;4-[4-([[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl]amino)phenoxy]-N-methylpyridine-2-carboxamide;4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide;Bay 43-9006;N-(4-chloro-3-(trifluoromethyl)phenyl)-((4-(2-(N-methyl-carbamoyl)(4-pyridyloxy))phenyl)amino)carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea;Nexavar;Raf1 kinase inhibitor ii;Sorafenib base;Sorafenib tsoh salt
| Catalog No. | PB14443 | CAS No. | 475207-59-1 |
| Chemical Name | Sorafenib | MDL No. | MFCD06411450 |
| Formula | C21H16ClF3N4O3 | Mol Weight | 464.825 |
| Synonyms | 1-(4-(2-(Methylcarbamoyl)pyridin-4-yloxy)phenyl)-3-(4-chloro-3-(trifluoromethyl)phenyl)urea;2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-;4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide;4-(4-[3-(4-Chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy)-pyridine-2-carboxylic acid methylamide;4-[4-([[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl]amino)phenoxy]-N-methyl-2-pyridinecarboxamide;4-[4-([[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl]amino)phenoxy]-N-methylpyridine-2-carboxamide;4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide;Bay 43-9006;N-(4-chloro-3-(trifluoromethyl)phenyl)-((4-(2-(N-methyl-carbamoyl)(4-pyridyloxy))phenyl)amino)carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea;Nexavar;Raf1 kinase inhibitor ii;Sorafenib base;Sorafenib tsoh salt | ||
| Boiling Point | Storage | Dry,sealed place. | |
| Description | Synblock offers CAS 475207-59-1, Sorafenib, NLT 98%, its formula is C21H16ClF3N4O3 and mol weight is 464.825 g/mol, its documents regarding Sorafenib, MFCD06411450, including MSDS, NMR, HPLC, LC-MS and more. | ||
| Related Categories | Others | ||
| * For R&D chemicals use. Not for human use directly. | |||
| GHS Pictogram | Signal Word: | ||
| Hazard Statements | |||
| Precautionary Statements | |||
| UN Number | |||
